Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

Inhibition of the epidermal growth factor receptor (EGFR) is an established treatment that extends patient survival across a variety of tumor types. EGFR inhibitors fall into two main categories: anti-EGFR monoclonal antibodies, such as cetuximab and panitumumab, and first-generation tyrosine kinase...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Hofheinz, Ralf-Dieter, Deplanque, Gaël, Komatsu, Yoshito, Kobayashi, Yoshimitsu, Ocvirk, Janja, Racca, Patrizia, Guenther, Silke, Zhang, Jun, Lacouture, Mario E., Jatoi, Aminah
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2016
Onderwerpen:
Symptom Management and Supportive Care
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153350/
https://ncbi.nlm.nih.gov/pubmed/27449521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0051
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items